Last reviewed · How we verify
NCT03278457: HCM-PET
Risk Stratification Using PET in HCM
trial testing Positron Emission Tomography in Hypertrophic Cardiomyopathy in 25 participants. Status unknown.
3 January 2018
Quick facts
| Lead sponsor | Region Gävleborg |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 25 |
| Start date | 3 May 2017 |
| Primary completion | 3 January 2018 |
| Estimated completion | 3 June 2018 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- Positron Emission Tomography
Conditions studied
- Hypertrophic Cardiomyopathy — all drugs for Hypertrophic Cardiomyopathy →
Sponsor
Region Gävleborg — full company profile →
Who can join
18 and older, any sex, with Hypertrophic Cardiomyopathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The overall rationale is to reduce the risk of sudden cardiac death in individuals with hypertrophic cardiomyopathy (HCM). The novel approach of this study is to correlate Positron Emission Tomography (PET) findings to ventricular arrhythmias detected by the implantable cardioverter defibrillator (ICD). This could potentially lead to an improved risk stratification of HCM patients.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Positron emission tomography (<sup>15</sup>O-water, <sup>11</sup>C-acetate, <sup>11</sup>C-HED) risk markers and nonsustained ventricular tachycardia in hypertrophic cardiomyopathy.
Magnusson P, Nordström J, Harms HJ, Lubberink M, et al · · 2020 · cited 13× · PMID 32140548 · DOI 10.1016/j.ijcha.2019.100452
Verify or expand the search:
- PubMed search for NCT03278457
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Positron Emission Tomography
Trials testing the same drug.
- NCT07229339 — Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung Cancer · Phase 2 · not yet recruiting
- NCT07441681 — Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive · Phase 3 · not yet recruiting
- NCT07365306 — Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant · Phase 2 · not yet recruiting
- NCT07147231 — Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cem · Phase 1, PHASE2 · recruiting
- NCT07572123 — Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem · Phase 2, PHASE3 · not yet recruiting
Other recruiting trials for Hypertrophic Cardiomyopathy
Currently open trials in the same condition.
- NCT07361289 — A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopa · recruiting
- NCT06490250 — Comparison of the Effects of Inspiratory Muscle Training and Baduanjin Exercises in Hypertrophic Cardiomyopathy Patients · NA · recruiting
- NCT06573723 — Institutional Registry of Rare Diseases · recruiting
- NCT06549608 — A Retrospective Cohort Study of Mavacamten Patient Support Program in Canada · active not recruiting
- NCT05939700 — Mavacamten Pregnancy Surveillance Program · recruiting
Other Region Gävleborg trials
Trials by the same sponsor.
- NCT06035705 — Patient Acuity in Somatic In-patient Care · recruiting
- NCT05573867 — Digital Coaching With" Physical Activity on Prescription ( FaR) to Increase Physical Activity and Reduce Post Stroke Fat · NA · unknown
- NCT05211466 — Digital Care Chains in Health Care - a Study of Care Consumption, Care Quality, Work Environment and Well-being · completed
- NCT05174390 — Thumb ECG IncidenT Atrial fibrillatioN in Diabetes Mellitus · unknown
- NCT03301662 — Transient Electrocardiogram Assessment in Stroke Evaluation · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03278457 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Region Gävleborg
- Last refreshed: 11 September 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03278457.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing